AU2001284419A1 - Novel polypeptides and anti-hiv drugs containing the same - Google Patents

Novel polypeptides and anti-hiv drugs containing the same

Info

Publication number
AU2001284419A1
AU2001284419A1 AU2001284419A AU8441901A AU2001284419A1 AU 2001284419 A1 AU2001284419 A1 AU 2001284419A1 AU 2001284419 A AU2001284419 A AU 2001284419A AU 8441901 A AU8441901 A AU 8441901A AU 2001284419 A1 AU2001284419 A1 AU 2001284419A1
Authority
AU
Australia
Prior art keywords
residue
citrulline
alanine
ornithine
lysine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284419A
Other languages
English (en)
Inventor
Nobutaka Fujii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Publication of AU2001284419A1 publication Critical patent/AU2001284419A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/857—Fish; fish eggs; shell fish; crustacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001284419A 2000-09-05 2001-09-05 Novel polypeptides and anti-hiv drugs containing the same Abandoned AU2001284419A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-269296 2000-09-05
JP2000269296 2000-09-05
JP2001092306 2001-03-28
JP2001-92306 2001-03-28
PCT/JP2001/007668 WO2002020561A1 (fr) 2000-09-05 2001-09-05 Nouveaux polypeptides et medicaments anti-vih contenant lesdits polypeptides

Publications (1)

Publication Number Publication Date
AU2001284419A1 true AU2001284419A1 (en) 2002-03-22

Family

ID=26599311

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284419A Abandoned AU2001284419A1 (en) 2000-09-05 2001-09-05 Novel polypeptides and anti-hiv drugs containing the same

Country Status (8)

Country Link
US (2) US7138488B2 (de)
EP (1) EP1323730B1 (de)
JP (1) JP4808363B2 (de)
AT (1) ATE465170T1 (de)
AU (1) AU2001284419A1 (de)
CA (1) CA2421183C (de)
DE (1) DE60136373D1 (de)
WO (1) WO2002020561A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8435939B2 (en) * 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
ES2403932T3 (es) 2002-08-27 2013-05-22 Biokine Therapeutics Ltd. Antagonista de CXCR4 y uso del mismo
JP4781621B2 (ja) * 2002-08-27 2011-09-28 バイオカイン セラピューティックス リミテッド Ｃｘｃｒ４拮抗薬およびその用途
EP1898943B1 (de) * 2005-05-25 2012-10-10 Hadasit Medical Research Services & Development Ltd. Cxcr4-antagonisten für wundheilung und reepithelialisierung
CA2673484A1 (en) 2006-12-21 2008-06-26 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy
MX2011013459A (es) * 2009-06-14 2012-05-08 Biokine Therapeutics Ltd Terapia de peptido para incrementar los niveles de plaquetas.
US20130303460A1 (en) 2011-01-10 2013-11-14 Biokine Therapeutics Ltd. Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
EP2841084B1 (de) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
AU2014240733B2 (en) 2013-03-24 2018-11-22 Biolinerx Ltd. Methods of treating myeloid leukemia
EP3062809B1 (de) 2013-10-31 2020-07-08 Biokine Therapeutics Ltd. Ein cxcr4 peptide inhibitor zur behandlung von akuter myeloischer leukämie mit einer flt3-mutation
US20170042893A1 (en) 2014-02-03 2017-02-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of casein kinase i inhibitors for depleting stem cells
MX2017016844A (es) 2015-07-16 2018-08-15 Biokine Therapeutics Ltd Composiciones y procedimientos para tratar cancer.
US20180221393A1 (en) 2015-08-03 2018-08-09 Biokine Therapeutics Ltd. Cxcr4 binding agents for treatment of diseases
ES2830726T3 (es) 2016-02-23 2021-06-04 Biolinerx Ltd Método para seleccionar un régimen de tratamiento para la leucemia mieloide aguda (LMA)
US20210338767A1 (en) 2018-09-25 2021-11-04 Biolinerx Ltd. Methods of selecting treatment for cxcr4-associated cancer
CA3205663A1 (en) 2020-12-30 2022-07-07 Biolinerx Ltd. Process for manufacturing peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69416824T2 (de) 1993-10-14 1999-07-08 Seikagaku Kogyo Co Ltd Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen
DE69914463T2 (de) 1998-03-13 2004-11-11 The University Of British Columbia, Vancouver Therapeutische chemokine rezeptor antagonisten
WO2001064716A1 (fr) 2000-03-03 2001-09-07 Nobutaka Fujii Composes antiviraux
ES2403932T3 (es) 2002-08-27 2013-05-22 Biokine Therapeutics Ltd. Antagonista de CXCR4 y uso del mismo

Also Published As

Publication number Publication date
JPWO2002020561A1 (ja) 2004-01-15
US7138488B2 (en) 2006-11-21
US20060264605A1 (en) 2006-11-23
EP1323730A4 (de) 2005-01-05
WO2002020561A1 (fr) 2002-03-14
JP4808363B2 (ja) 2011-11-02
US20040116655A1 (en) 2004-06-17
CA2421183A1 (en) 2003-03-04
EP1323730A1 (de) 2003-07-02
CA2421183C (en) 2015-06-16
ATE465170T1 (de) 2010-05-15
DE60136373D1 (de) 2008-12-11
EP1323730B1 (de) 2010-04-21
US7595298B2 (en) 2009-09-29

Similar Documents

Publication Publication Date Title
AU2001284419A1 (en) Novel polypeptides and anti-hiv drugs containing the same
EP0254080A3 (en) Malonic acid derivatives and methods for their synthesis
AU9174398A (en) Peptides
ATE170875T1 (de) Analoge vom menschlichen insulin
AU1448983A (en) Dynorphin amide analogs
WO2000012541A3 (en) Cytotoxic peptides modified by bulky or lipophilic moieties
RU95112539A (ru) Новый полипептид и фармацевтическая композиция против вич-инфекции
EP0528312A3 (de) Zyklische Peptide und ihre Verwendung
DE69429176D1 (en) Protegrine
WO2001098324A8 (en) Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
EP0506628A3 (de) Aminoacyl und Oligopeptidylderivate von Allopurinol mit immunostimulierender Wirkung und diese enthaltende pharmazeutische Zubereitungen
WO2002048180A3 (de) Peptide und/oder proteine sowie verwendung desselben zur herstellung eines therapeutischen und/oder präventiven arzneimittels
WO2001027136A3 (fr) Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
AU1599892A (en) Novel polypeptides with affinity to lipopolysaccharides and their uses
AU585167B2 (en) Novel substrate peptides
GR3020507T3 (en) New peptide derivatives, process to prepare them and their use as medicaments
DE3665462D1 (en) Pharmacologically active peptides
AU773969C (en) Novel tachykinin peptides, precursor peptides thereof and genes encoding the same
SG43028A1 (en) Process for the preparation of an alpha-amino acid amide which may be used in peptide synthesis
WO1999057262A3 (de) An metallionen bindendes peptid
IL150045A0 (en) Compositions and methods for detecting stress-inducible proteins
ATE305478T1 (de) Topoisomerase-ii inhibitoren
WO2003000718A3 (en) Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome